These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34342378)

  • 81. Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Burge RT; Disch DP; Gelwicks S; Zhang X; Krege JH
    Osteoporos Int; 2017 Mar; 28(3):799-809. PubMed ID: 28028555
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Impact of Stroke History on the Risk of Recurrent Hip Fracture or Major Osteoporotic Fractures among Patients with Incident Hip Fracture: A Nationwide Cohort Study.
    Hjelholt TJ; Johnsen SP; Brynningsen PK; Andersen G; Pedersen AB
    J Bone Miner Res; 2023 Feb; 38(2):278-287. PubMed ID: 36533810
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Orthopedic-Metabolic Collaborative Management for Osteoporotic Hip Fracture.
    Rotman-Pikielny P; Frankel M; Lebanon OT; Yaacobi E; Tamar M; Netzer D; Nabriski D; Nyska M; Brin YS
    Endocr Pract; 2018 Aug; 24(8):718-725. PubMed ID: 30084682
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficacy and safety of teriparatide in bisphosphonate-pretreated and treatment-naive patients with osteoporosis at high risk of fracture: Post hoc analysis of a prospective observational study.
    Yoshiki F; Nishikawa A; Taketsuna M; Kajimoto K; Enomoto H
    J Orthop Sci; 2017 Mar; 22(2):330-338. PubMed ID: 28038880
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [TBL] [Abstract][Full Text] [Related]  

  • 86. 3D Finite Element Models Reconstructed From 2D Dual-Energy X-Ray Absorptiometry (DXA) Images Improve Hip Fracture Prediction Compared to Areal BMD in Osteoporotic Fractures in Men (MrOS) Sweden Cohort.
    Grassi L; Väänänen SP; Jehpsson L; Ljunggren Ö; Rosengren BE; Karlsson MK; Isaksson H
    J Bone Miner Res; 2023 Sep; 38(9):1258-1267. PubMed ID: 37417707
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bone mineral density enhances use of clinical risk factors in predicting ten-year risk of osteoporotic fractures in Chinese men: the Hong Kong Osteoporosis Study.
    Bow CH; Tsang SW; Loong CH; Soong CS; Yeung SC; Kung AW
    Osteoporos Int; 2011 Nov; 22(11):2799-807. PubMed ID: 21234548
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
    Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
    Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population.
    Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1178-1190. PubMed ID: 29083977
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data.
    Curtis JR; Yun H; Lange JL; Matthews R; Sharma P; Saag KG; Delzell E
    Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1855-63. PubMed ID: 22730364
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model.
    Vizcarra P; Moreno A; Vivancos MJ; Muriel García A; Ramirez Schacke M; González-Garcia J; Curran A; Palacios R; Sánchez Guirao AJ; Reus Bañuls S; Moreno Guillén S; Casado JL;
    J Bone Miner Res; 2023 Oct; 38(10):1443-1452. PubMed ID: 37545089
    [TBL] [Abstract][Full Text] [Related]  

  • 93. How well do the FRAX (Australia) and Garvan calculators predict incident fractures? Data from the Geelong Osteoporosis Study.
    Holloway-Kew KL; Zhang Y; Betson AG; Anderson KB; Hans D; Hyde NK; Nicholson GC; Pocock NA; Kotowicz MA; Pasco JA
    Osteoporos Int; 2019 Oct; 30(10):2129-2139. PubMed ID: 31317250
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Fracture prediction from repeat BMD measurements in clinical practice.
    Leslie WD; Brennan-Olsen SL; Morin SN; Lix LM
    Osteoporos Int; 2016 Jan; 27(1):203-10. PubMed ID: 26243362
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis.
    Merlijn T; Swart KMA; van der Horst HE; Netelenbos JC; Elders PJM
    Osteoporos Int; 2020 Feb; 31(2):251-257. PubMed ID: 31838551
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.
    Ferrari S; Reginster JY; Brandi ML; Kanis JA; Devogelaer JP; Kaufman JM; Féron JM; Kurth A; Rizzoli R
    Arch Osteoporos; 2016 Dec; 11(1):37. PubMed ID: 27800591
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
    Khalid S; Calderon-Larrañaga S; Hawley S; Ali MS; Judge A; Arden N; van Staa T; Cooper C; Javaid MK; Prieto-Alhambra D
    Clin Epidemiol; 2018; 10():1417-1431. PubMed ID: 30349390
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Impact of bisphosphonate compliance on the risk of osteoporotic fracture in France.
    Belhassen M; Cortet B; Confavreux CB; Lamezec L; Ginoux M; Van Ganse E
    Arch Osteoporos; 2018 Oct; 13(1):113. PubMed ID: 30341636
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries.
    Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN
    Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.